← Latest briefing

World News

Spiraling health costs and medicine shortages force Iranians to delay care

Patients are paying more than 70% of healthcare expenses out of pocket as drug prices surge and critical medications run short.

The short version

  • Soaring medication costs and widespread shortages in Iran are forcing patients to delay or halt critical medical treatments, including chemotherapy and insulin therapy.
  • A single chemotherapy session can cost roughly six times the monthly minimum wage in Iran, pushing patients to seek alternative unofficial channels that risk delivering expired or counterfeit drugs.
  • Economic pressures, currency depreciation, international banking restrictions, and insurance payment delays are driving the severe healthcare crisis.

Key facts

  • Patients in Iran now pay more than 70% of healthcare costs out of pocket, a significant rise from the original target of roughly 30%.[Deutsche Welle]
  • Salman Eshaghi, spokesman for Iran's parliamentary Health and Treatment Committee, reported that 43 medicines are in critical shortage and nearly 1,000 face some level of shortage.[Deutsche Welle]
  • A single session of chemotherapy can cost around 100 million Iranian tomans, which is about six times the country's monthly minimum wage of 16.6 million tomans.[Deutsche Welle]
  • An Iranian pharmaceutical firm recently raised prices for 82 of its products by an average of about 120%, with some individual drugs seeing increases of over 500%.[Deutsche Welle]
  • The monthly cost of four NovoRapid insulin pens after insurance has climbed from about 280,000 tomans to roughly 1.1 million tomans.[Deutsche Welle]

What remains uncertain

  • It is unclear how much of the shortage is driven by actual foreign currency availability versus supply chain bottlenecks, as Iran's Central Bank governor stated currency allocated for medical goods rose by 30% while the Food and Drug Administration reported money transfers had nearly halted for months.[Deutsche Welle]

Sources